Premium
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance
Author(s) -
Breccia Massimo,
Bocchia Monica,
Cannella Laura,
Defina Marzia,
Ippoliti Micaela,
Loglisci Giuseppina,
Santopietro Michelina,
Lauria Francesco,
Alimena Giuliana
Publication year - 2010
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2010.08187.x
Subject(s) - chronic myeloid leukaemia , imatinib , persistence (discontinuity) , medicine , oncology , cancer research , immunology , myeloid leukemia , geotechnical engineering , engineering
[No abstract available